Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00036582 · ClinicalTrials.gov registry record · Phase 3
Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents
A Phase 3 study, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- Phase 3
- Development phase
- 116
- Enrollment target
NCT00036582 is a Phase 3 study that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 116 participants.
The verdict
NCT00036582, a Phase 3 study, has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 116 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and effectiveness of clozapine in children and adolescents with treatment resistant bipolar disorder. This study will also explore how the brain functions in early-onset bipolar disorder.
Interventions
- DRUG Clozapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2002-05 |
| Est. Completion | 2004-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00036582
The ClinicalTrials.gov registry entry for NCT00036582 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clozapine is the first listed.
NCT00036582 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00036582 about?
NCT00036582 is a clinical study titled "Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents". The purpose of this study is to determine the safety and effectiveness of clozapine in children and adolescents with treatment resistant bipolar disorder. This study will also explore how the brain functions in early-onset bipolar disorder.
What is the current status of trial NCT00036582?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 116 participants. The study started on 2002-05. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00036582?
The interventions under investigation include: Clozapine (DRUG).
Who is sponsoring clinical trial NCT00036582?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.